BeOne Medicines Ltd.
BEIGF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651308
In the last 90 days, BeOne Medicines Ltd. insiders filed 0 open-market purchases and 14 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesONC
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by BeOne Medicines Ltd. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 14 filings
- 6 insiders, $309.4M in total
- Insiders trading
- 6
- Net value
- −$309.4M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for BeOne Medicines Ltd., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Baker Julian | Director | 8,099,179Indirect | Sep 16, 2026 | 3 |
| Baker Felix | Director | 8,099,179Indirect | Sep 16, 2026 | 3 |
| Baker Bros. Advisors LP | Director | 8,099,179Indirect | Sep 16, 2026 | 3 |
| Baker Brothers Life Sciences LP | Director | 8,099,179Indirect | Sep 16, 2026 | 3 |
| 667, L.P. | Director | 8,099,179Indirect | Sep 16, 2026 | 3 |
| Baker Bros. Advisors (GP) LLC | Director | 8,099,179Indirect | Sep 16, 2026 | 3 |
| Wang Xiaodong | Director, Other: Chair, Scientific Advisory Brd | 0 | Sep 10, 2026 | 3 |
| Ball Titus B. | Principal Accounting Officer | 0 | Sep 3, 2026 | 3 |
| Wu Xiaobin | President and COO | 0 | Aug 27, 2026 | 8 |
| Lee Chan Henry | SVP, General Counsel | 0 | Aug 13, 2026 | 16 |
| Oyler John | Chief Executive Officer | 0 | Aug 12, 2026 | 13 |
| Rosenberg Aaron | Chief Financial Officer | 0 | Aug 5, 2026 | 3 |
| Wang Lai | President, Global Head of R&D | 0 | Jun 25, 2026 | 6 |
| Hooper Anthony C | Director | 83,720 | Jun 15, 2026 | 1 |
| Sharp Shalini | Director | 38,116 | Jun 15, 2026 | 1 |
| Brandicourt Olivier | Director | 46,306 | Jun 15, 2026 | 1 |
| Riva Alessandro | Director | 73,164 | Jun 15, 2026 | 2 |
| Dugan Margaret | Director | 73,164 | Jun 15, 2026 | 2 |
| Sawyers Charles Lazelle | Director | 18,984 | Jun 15, 2026 | 1 |
| Mooney Elizabeth Fisher | Director | 18,980 | Jun 15, 2026 | 1 |
| Yi Qingqing | Director | 0 | Jun 3, 2026 | 1 |
| Sanders Corazon (Corsee) D. | Director | 0 | May 27, 2026 | 2 |
| Hillhouse Investment Management, Ltd. | 10% Owner | 125,045,741Indirect | Dec 4, 2024 | 0 |
| HHLR Advisors, Ltd. | 10% Owner | 125,045,741Indirect | Dec 4, 2024 | 0 |
| Wang Julia Aijun | Chief Financial Officer | 0 | Jul 3, 2024 | 0 |
| Glazer Donald W. | Director | 2,718,464 | Jun 7, 2024 | 0 |
| Malley Thomas | Director | 46,696 | Jun 20, 2023 | 0 |
| Huang Jane | CMO, Hematology | 0 | Dec 16, 2021 | 0 |
| Amgen Inc | 10% Owner | 18,943,802 | Sep 13, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2022 (view filing) | Aug 5-8 | 4 days | Wang XiaodongDirector, Other: Chair, Scientific Advisory Brd | SSaleAmerican Depositary Shares | −11.1K | $197.91 | −$2.19M | −100.0%0 after | 15 lots |
| Jul 18, 2022 (view filing) | Jul 1 | 17 days | Wang Julia AijunChief Financial Officer | SSaleAmerican Depositary Shares | −317 | $158.50 | −$50.2K | −100.0%0 after | Amended |
| Jun 28, 2022 (view filing) | Jun 27 | 1 day | Wang LaiGlobal Head of R&D | SSaleAmerican Depositary Shares | −458 | $177.32 | −$81.2K | −100.0%0 after | |
| Jun 22, 2022 (view filing) | Jun 17-21 | 5 days | Wang LaiGlobal Head of R&D | SSaleAmerican Depositary Shares | −1.17K | $145.35 | −$169.8K | −100.0%0 after | 2 lots |
| Jun 22, 2022 (view filing) | Jun 17-21 | 5 days | Wu XiaobinPresident, COO & GM China | SSaleAmerican Depositary Shares | −1.59K | $142.63 | −$226.5K | −100.0%0 after | 2 lots |
| Jun 21, 2022 (view filing) | Jun 17 | 4 days | Wang Julia AijunChief Financial Officer | SSaleAmerican Depositary Shares | −161 | $136.64 | −$22.0K | −100.0%0 after | |
| Jun 8, 2022 (view filing) | Jun 6 | 2 days | Wang LaiGlobal Head of R&D | SSaleAmerican Depositary Shares | −660 | $142.00 | −$93.7K | −100.0%0 after | |
| Jun 8, 2022 (view filing) | Jun 6 | 2 days | Wu XiaobinPresident, COO & GM China | SSaleAmerican Depositary Shares | −3.41K | $141.99 | −$484.2K | −100.0%0 after | |
| May 6, 2022 (view filing) | May 5 | 1 day | Wu XiaobinPresident, COO & GM China | SSaleAmerican Depositary Shares | −6.72K | $164.35 | −$1.11M | −100.0%0 after | 7 lots |
| Dec 16, 2021 (view filing) | Dec 14 | 2 days | Huang JaneCMO, Hematology | SSaleAmerican Depositary Shares | −1.50K | $278.14 | −$417.2K | −100.0%0 after | 6 lots |
| Dec 2, 2021 (view filing) | Dec 1 | 1 day | Huang JaneCMO, Hematology | SSaleAmerican Depositary Shares | −1.05K | $359.86 | −$377.5K | −100.0%0 after | 2 lots |
| Nov 19, 2021 (view filing) | Nov 17 | 2 days | Huang JaneCMO, Hematology | SSaleAmerican Depositary Shares | −1.50K | $381.34 | −$572.0K | −100.0%0 after | 9 lots |
| Nov 10, 2021 (view filing) | Nov 8 | 2 days | Wang XiaodongDirector, Other: Chair, Scientific Advisory Brd | SSaleAmerican Depositary Shares | −4.50K | $350.04 | −$1.58M | −100.0%0 after | 14 lots |
| Nov 10, 2021 (view filing) | Nov 8 | 2 days | Wang XiaodongDirector, Other: Chair, Scientific Advisory Brd | SSaleAmerican Depositary Shares | −4.50K | $349.81 | −$1.57M | −100.0%0 after | 13 lots |
| Nov 10, 2021 (view filing) | Nov 8-9 | 2 days | Wu XiaobinPresident, COO & GM China | SSaleAmerican Depositary Shares | −10.0K | $358.27 | −$3.58M | −100.0%0 after | 22 lots |
| Oct 21, 2021 (view filing) | Oct 19 | 2 days | Huang JaneCMO, Hematology | SSaleAmerican Depositary Shares | −1.50K | $372.78 | −$559.2K | −100.0%0 after | 7 lots |
| Sep 22, 2021 (view filing) | Sep 20 | 2 days | Huang JaneCMO, Hematology | SSaleAmerican Depositary Shares | −6.00K | $397.96 | −$2.39M | −100.0%0 after | 14 lots |
| Sep 16, 2021 (view filing) | Sep 14-15 | 2 days | Oyler JohnChief Executive Officer | SSale | −347.8K | $28.82 | −$10.0M | −16.7%1.74M after | 2 lots |
| Sep 16, 2021 (view filing) | Sep 14-15 | 2 days | Oyler JohnChief Executive Officer | SSaleAmerican Depositary Shares | −64.0K | $371.14 | −$23.8M | −100.0%0 after | 17 lots |
| Sep 15, 2021 (view filing) | Sep 13 | 2 days | Huang JaneCMO, Hematology | SSaleAmerican Depositary Shares | −12.9K | $358.14 | −$4.62M | −100.0%0 after | 8 lots |
| Sep 13, 2021 (view filing) | Sep 10 | 3 days | Amgen Inc10% Owner | PPurchaseAmerican Depositary Shares | +165.5K | $302.06 | +$50.0M | +0.9%18.9M after | |
| Sep 2, 2021 (view filing) | Aug 31-Sep 1 | 2 days | Oyler JohnChief Executive Officer | SSale | −204.4K | $24.09 | −$4.92M | −6.5%2.92M after | 3 lots |
| Sep 2, 2021 (view filing) | Aug 31-Sep 2 | 2 days | Oyler JohnChief Executive Officer | SSaleAmerican Depositary Shares | −84.3K | $317.54 | −$26.8M | −100.0%0 after | 22 lots |
| Sep 2, 2021 (view filing) | Sep 1-2 | 1 day | Huang JaneCMO, Hematology | SSaleAmerican Depositary Shares | −1.09K | $318.88 | −$346.6K | −100.0%0 after | 2 lots |
| Aug 5, 2021 (view filing) | Aug 4-5 | 1 day | Oyler JohnChief Executive Officer | SSale | −83.2K | $25.97 | −$2.16M | −1.9%4.22M after | 2 lots |
| Aug 5, 2021 (view filing) | Aug 4-5 | 1 day | Oyler JohnChief Executive Officer | SSaleAmerican Depositary Shares | −42.1K | $342.51 | −$14.4M | −100.0%0 after | 22 lots |
| Aug 5, 2021 (view filing) | Aug 3 | 2 days | Oyler JohnChief Executive Officer | SSale | −41.4K | $25.17 | −$1.04M | −0.8%4.85M after | |
| Aug 5, 2021 (view filing) | Aug 3 | 2 days | Oyler JohnChief Executive Officer | SSaleAmerican Depositary Shares | −42.0K | $337.48 | −$14.2M | −100.0%0 after | 18 lots |
| Jul 22, 2021 (view filing) | Jul 22 | Same day | Oyler JohnChief Executive Officer | SSale | −57.9K | $23.71 | −$1.37M | −1.1%5.43M after | |
| Jul 22, 2021 (view filing) | Jul 22 | Same day | Oyler JohnChief Executive Officer | SSaleAmerican Depositary Shares | −11.3K | $317.98 | −$3.60M | −100.0%0 after | 12 lots |
| Jul 22, 2021 (view filing) | Jul 20-21 | 2 days | Oyler JohnChief Executive Officer | SSale | −39.6K | $24.60 | −$974.2K | −0.7%5.64M after | 2 lots |
| Jul 22, 2021 (view filing) | Jul 20-21 | 2 days | Oyler JohnChief Executive Officer | SSaleAmerican Depositary Shares | −31.3K | $313.70 | −$9.80M | −100.0%0 after | 15 lots |
| Jul 19, 2021 (view filing) | Jul 15 | 4 days | Huang JaneCMO, Hematology | SSaleAmerican Depositary Shares | −21.0K | $332.42 | −$6.98M | −100.0%0 after | 6 lots |
| Jul 8, 2021 (view filing) | Jul 8 | Same day | Oyler JohnChief Executive Officer | SSale | −51.3K | $24.24 | −$1.24M | −0.8%6.09M after | |
| Jul 8, 2021 (view filing) | Jul 7-8 | 1 day | Oyler JohnChief Executive Officer | SSaleAmerican Depositary Shares | −16.2K | $318.62 | −$5.16M | −100.0%0 after | 15 lots |
| Jul 8, 2021 (view filing) | Jul 6-7 | 2 days | Oyler JohnChief Executive Officer | SSale | −85.0K | $25.29 | −$2.15M | −1.3%6.34M after | 2 lots |
| Jul 8, 2021 (view filing) | Jul 6-7 | 2 days | Oyler JohnChief Executive Officer | SSaleAmerican Depositary Shares | −38.8K | $318.52 | −$12.4M | −99.2%300 after | 23 lots |
| Jul 8, 2021 (view filing) | Jul 6 | 2 days | Wu XiaobinPresident, COO & GM China | SSaleAmerican Depositary Shares | −10.2K | $325.53 | −$3.31M | −100.0%0 after | 8 lots |
| Jul 1, 2021 (view filing) | Jul 1 | Same day | Wang XiaodongDirector, Other: Chair, Scientific Advisory Brd | SSaleAmerican Depositary Shares | −4.85K | $348.16 | −$1.69M | −100.0%0 after | 6 lots |
| Jul 1, 2021 (view filing) | Jul 1 | Same day | Wang Julia AijunChief Financial Officer | SSaleAmerican Depositary Shares | −308 | $349.06 | −$107.5K | −100.0%0 after |